NVP-ACC789 is primarily used in the field of pharmaceutical research and development. It is being investigated for its potential as a therapeutic agent, particularly in targeting specific biological pathways involved in diseases such as cancer or inflammatory conditions. Its application extends to preclinical studies, where it is tested for efficacy, safety, and pharmacokinetic properties. Researchers are also exploring its use in combination therapies to enhance treatment outcomes. Additionally, NVP-ACC789 serves as a valuable tool in understanding molecular mechanisms and validating drug targets in biochemical assays.